Cargando…

Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer

Tamoxifen is an effective anti-estrogen treatment for patients with estrogen receptor-positive (ER+) breast cancer, however, tamoxifen resistance is frequently observed. To elucidate the underlying molecular mechanisms of tamoxifen resistance, we performed a systematic analysis of miRNA-mediated gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Tejal, Elias, Daniel, Stenvang, Jan, Alves, Carla L., Teng, Fei, Lyng, Maria B., Lykkesfeldt, Anne E., Brünner, Nils, Wang, Jun, Gupta, Ramneek, Workman, Christopher T., Ditzel, Henrik J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302986/ https://www.ncbi.nlm.nih.gov/pubmed/27528030 http://dx.doi.org/10.18632/oncotarget.11136

Ejemplares similares

Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties
por: Lin, Xue, et al.
Publicado: (2013)

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer
por: Gravgaard, KH, et al.
Publicado: (2011)

SAT-LB130 Tamoxifen Affects MiRNA Expression in Uterus and Breast Tamoxifen Affects MiRNA Expression in Uterus and Breast Tamoxifen Affects MiRNA Expression in Uterus and Breast
por: Gulyaeva, Lyudmila, et al.
Publicado: (2020)

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer
por: Alves, Carla L., et al.
Publicado: (2018)

Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2012)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
por: Elias, D., et al.
Publicado: (2019)

miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations
por: Thomsen, Karina G., et al.
Publicado: (2015)

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines
por: Ehlers, Natasja S, et al.
Publicado: (2012)

Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2013)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Løkkegaard, Sanne, et al.
Publicado: (2021)

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer
por: Huang, Peide, et al.
Publicado: (2021)

miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
por: Klinge, Carolyn M.
Publicado: (2015)

The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells
por: Hansen, Stine Ninel, et al.
Publicado: (2016)

MiRNA Regulatory Functions in Photoreceptors
por: Pawlick, Julia Sophie, et al.
Publicado: (2021)

Development and characterization of a tamoxifen-resistant breast carcinoma xenograft
por: Naundorf, H, et al.
Publicado: (2000)

Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis
por: Guo, Yongchen, et al.
Publicado: (2017)

Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women
por: Kodahl, Annette R., et al.
Publicado: (2014)

The circRNA-miRNA/RBP regulatory network in myocardial infarction
por: Zhang, Lei, et al.
Publicado: (2022)

Identification of genes for normalization of real-time RT-PCR data in breast carcinomas
por: Lyng, Maria B, et al.
Publicado: (2008)

miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer
por: Kim, Ye Sol, et al.
Publicado: (2016)

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer
por: Alves, Carla L., et al.
Publicado: (2023)

Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer
por: Yin, Teng-Fei, et al.
Publicado: (2021)

Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer
por: Zhang, Wenyu, et al.
Publicado: (2014)

Regulatory effects of miRNA on gastric cancer cells
por: YANG, OUYANG, et al.
Publicado: (2014)

Regulatory Role of miRNAs and lncRNAs in Gout
por: Shu, Jianlong, et al.
Publicado: (2022)

KRAS Hijacks the miRNA Regulatory Pathway in Cancer
por: Bortoletto, Angelina S., et al.
Publicado: (2023)

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.
por: Lykkesfeldt, A. E., et al.
Publicado: (1984)

Investigation of miRNA Biology by Bioinformatic Tools and Impact of miRNAs in Colorectal Cancer—Regulatory Relationship of c-Myc and p53 with miRNAs
por: Xi, Yaguang, et al.
Publicado: (2007)

Repertoire of Bovine miRNA and miRNA-Like Small Regulatory RNAs Expressed upon Viral Infection
por: Glazov, Evgeny A., et al.
Publicado: (2009)

Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer
por: Wang, Wenwen, et al.
Publicado: (2021)

Identification of Nitrogen Starvation-Responsive miRNAs to Reveal the miRNA-Mediated Regulatory Network in Betula luminifera
por: Lin, Yan, et al.
Publicado: (2022)

Identification of potential miRNA-mRNA regulatory network and the key miRNAs in intramuscular and subcutaneous adipose
por: Feng, Hui, et al.
Publicado: (2022)

A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol
por: Kümler, Iben, et al.
Publicado: (2015)

miRModuleNet: Detecting miRNA-mRNA Regulatory Modules
por: Yousef, Malik, et al.
Publicado: (2022)

Apple miRNAs and tasiRNAs with novel regulatory networks
por: Xia, Rui, et al.
Publicado: (2012)

Exploring the miRNA Regulatory Network Using Evolutionary Correlations
por: Obermayer, Benedikt, et al.
Publicado: (2014)

Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity
por: Zhao, Luqing, et al.
Publicado: (2012)

Role of miRNA in the Regulatory Mechanisms of Estrogens in Cardiovascular Ageing
por: Pérez-Cremades, Daniel, et al.
Publicado: (2018)

Regulatory role of miRNA-23a in diabetic retinopathy
por: Sun, Lihui, et al.
Publicado: (2021)

Regulatory miRNA–mRNA Networks in Parkinson’s Disease
por: Santos-Lobato, Bruno Lopes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s8co50eb8o3p5ordgh5vhljcou